Introduction. Cytomegalovirus (CMV) is the leading cause of congenital infe
ction. 90-95% of infected infants are free of symptoms at birth and 5-10% a
re suffering from symptomatic disease.
Methods. Between 1.11.1997 and 31.10.1999 clinical, laboratory and demograp
hic data were monthly collected from standardized case reports. A congenita
l CMV infection was documented by isolation of virus, antigen or DNA in the
first or second week of life and serologically.
Results. There were 65 infants with congenital symptomatic CMV disease and
32 infants with presumtive congenital CMV disease. 45 out of 97 children we
re foreigners. 34 patients were treated with ganciclovir. In 13 of them the
indication for virostatic treatment did not seem to be correct.
Conclusion. The prevalence rate of congenital CMV infection in Germany is a
bout 2/1000 infants. A virostatic therapy should be initiated in children w
ith symptomatic CMV disease within the first 2 weeks of life.